Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride.

berberine chloride dermatological use escin human abdominal skin rabbit ear skin vesicles

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
15 Dec 2019
Historique:
received: 08 11 2019
revised: 09 12 2019
accepted: 13 12 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 19 12 2019
Statut: epublish

Résumé

Escin is a natural saponin, clinically used for the anti-edematous and anti-inflammatory effects. The aim of the study was to explore the possibility of converting escin into vesicle bilayer-forming component. The hyaluronidase inhibition activity of escin was evaluated after its formulation in escinosomes. Berberine chloride, a natural quaternary isoquinoline alkaloid isolated from several medicinal plants that is traditionally used for various skin conditions was loaded in the vesicles. The developed nanovesicles were characterized in terms of diameter, polydispersity, ζ-potential, deformability, recovery, encapsulation efficiency, stability, and release kinetics. Nanovesicle permeation properties through artificial membranes and rabbit ear skin were investigated using skin-PAMPA

Identifiants

pubmed: 31847489
pii: pharmaceutics11120682
doi: 10.3390/pharmaceutics11120682
pmc: PMC6955842
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : Progetto dipartimenti di eccellenza 2018-2022

Références

Int J Dermatol. 2018 Jun;57(6):646-660
pubmed: 29430629
Adv Pharm Bull. 2015 Nov;5(4):587-91
pubmed: 26819933
J Invest Dermatol. 2016 May;136(5):e43-e49
pubmed: 27107377
Eur J Pharm Sci. 2011 Nov 20;44(4):552-8
pubmed: 22001125
J Nat Prod. 2014 Apr 25;77(4):766-72
pubmed: 24593257
Eur J Pharm Biopharm. 2017 Oct;119:253-263
pubmed: 28652141
Int J Pharm. 2020 Jan 5;573:118817
pubmed: 31678520
Curr Med Chem. 2009;16(18):2261-88
pubmed: 19519390
J Control Release. 2017 Jan 28;246:174-182
pubmed: 27641832
Colloids Surf B Biointerfaces. 2014 Apr 1;116:121-7
pubmed: 24462780
Altern Ther Health Med. 2019 Oct 1;:null
pubmed: 31634873
Phytochemistry. 2007 Feb;68(3):275-97
pubmed: 17141815
Skin Pharmacol Physiol. 2015;28(5):245-9
pubmed: 25765467
J Liposome Res. 2011 Sep;21(3):237-44
pubmed: 21158702
Drug Deliv. 2000 Jan-Mar;7(1):7-13
pubmed: 10895414
ChemMedChem. 2016 Aug 19;11(16):1745-51
pubmed: 26999297
Chem Pharm Bull (Tokyo). 2012;60(1):121-8
pubmed: 22223383
Front Pharmacol. 2019 Aug 22;10:910
pubmed: 31507412
Drug Des Devel Ther. 2019 Sep 27;13:3425-3437
pubmed: 31631970
Arch Pharm (Weinheim). 1995 Oct;328(10):720-4
pubmed: 8554461
Curr Med Chem. 2019 Feb 27;:null
pubmed: 30827226
Eur J Pharm Biopharm. 2011 Sep;79(1):43-53
pubmed: 21272638
J Liposome Res. 2008;18(1):83-90
pubmed: 18348074
Planta Med. 2017 Mar;83(5):366-381
pubmed: 28178749
Skin Pharmacol Physiol. 2011;24(4):224-30
pubmed: 21455015
Planta Med. 2017 Mar;83(5):382-391
pubmed: 27002395
Curr Med Chem. 2019;26(24):4631-4656
pubmed: 30381065
Drug Deliv. 2007 Apr;14(4):195-9
pubmed: 17497351
Planta Med. 2017 Mar;83(5):412-419
pubmed: 27191581
Int J Pharm. 2018 Oct 5;549(1-2):76-86
pubmed: 30053489
Planta Med. 2018 Jul;84(9-10):736-742
pubmed: 29544228
Curr Med Chem. 2018 Feb 13;25(5):606-635
pubmed: 28990515
J Pharm Pharmacol. 2018 Jul;70(7):919-928
pubmed: 29600580
Int J Pharm. 2008 Aug 6;360(1-2):18-28
pubmed: 18524509
Eur J Pharm Biopharm. 2012 Apr;80(3):528-34
pubmed: 22142592
Handb Exp Pharmacol. 2010;(197):435-68
pubmed: 20217539
Planta Med. 2018 Nov;84(16):1219-1227
pubmed: 29797304
Langmuir. 2017 Oct 31;33(43):12351-12361
pubmed: 28985678
AAPS PharmSciTech. 2010 Sep;11(3):1466-75
pubmed: 20842541
Int J Nanomedicine. 2007;2(3):419-25
pubmed: 18019840
J Control Release. 2016 Aug 10;235:337-351
pubmed: 27297779
Pharmaceutics. 2019 Jan 16;11(1):null
pubmed: 30654435
Planta Med. 2017 Mar;83(5):420-425
pubmed: 27002394
Eur J Pharm Sci. 2012 Apr 11;45(5):698-707
pubmed: 22326705
Pharmaceutics. 2011 Dec 15;3(4):954-70
pubmed: 24309316

Auteurs

Giulia Vanti (G)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.

Daniele Bani (D)

Department of Experimental and Clinical Medicine, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.

Maria Cristina Salvatici (MC)

Centro di Microscopie Elettroniche "Laura Bonzi" (Ce.M.E.), ICCOM, National Research Council (CNR), Via Madonna del Piano 10, 50019 Sesto Fiorentino (FI), Italy.

Maria Camilla Bergonzi (MC)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.

Anna Rita Bilia (AR)

Department of Chemistry, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.

Classifications MeSH